Skip to content

Nektar Therapeutics: filings

Every Nektar Therapeutics annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 2026341010001193125-26-349805
10-Q2026-05-08fiscal Q1 202634710001193125-26-212596
10-K2026-03-13fiscal FY 202546930001193125-26-104547
10-Q2025-11-07fiscal Q3 2025381140001193125-25-270230
10-Q2025-08-08fiscal Q2 2025381100000950170-25-105275
10-Q2025-05-09fiscal Q1 202538800000950170-25-067279
10-K2025-03-14fiscal FY 2024501010000950170-25-039389
10-Q2024-11-08fiscal Q3 2024441270000950170-24-123570
10-Q2024-08-09fiscal Q2 2024431220000950170-24-094231
10-Q2024-05-10fiscal Q1 202442880000950170-24-057312
10-K2024-03-05fiscal FY 2023491280000950170-24-026249
10-Q2023-11-08fiscal Q3 2023441280000950170-23-060475
10-Q2023-08-09fiscal Q2 2023441240000906709-23-000012
10-Q2023-05-10fiscal Q1 202343900000906709-23-000008
10-K2023-02-28fiscal FY 2022501320000906709-23-000004
10-Q2022-11-04fiscal Q3 2022401200000906709-22-000019
10-Q2022-08-05fiscal Q2 2022401160000906709-22-000014
10-Q2022-05-06fiscal Q1 202240840000906709-22-000010
10-K2022-03-01fiscal FY 2021501800000906709-22-000005
10-Q2021-11-05fiscal Q3 2021421260000906709-21-000018
10-Q2021-08-06fiscal Q2 2021421220000906709-21-000014
10-Q2021-05-07fiscal Q1 202138800000906709-21-000008
10-K2021-02-26fiscal FY 2020511810000906709-21-000005
10-Q2020-11-06fiscal Q3 2020391120000906709-20-000017
10-Q2020-08-07fiscal Q2 2020391080000906709-20-000014
10-Q2020-05-08fiscal Q1 202037780000906709-20-000009
10-K2020-02-28fiscal FY 2019511800000906709-20-000004
10-Q2019-11-07fiscal Q3 2019451300000906709-19-000010
10-Q2019-08-09fiscal Q2 2019451280000906709-19-000006
10-Q2019-05-09fiscal Q1 201940810001564590-19-017467
10-K2019-03-01fiscal FY 2018481730001564590-19-005639
10-Q2018-11-08fiscal Q3 2018421140001564590-18-028218
10-Q2018-08-09fiscal Q2 2018421160001564590-18-020709
10-Q2018-05-10fiscal Q1 201831640001564590-18-012975
10-K2018-03-01fiscal FY 2017401460001564590-18-004105
10-Q2017-11-08fiscal Q3 2017351020001564590-17-022445
10-Q2017-08-09fiscal Q2 201731860001564590-17-016709
10-Q2017-05-10fiscal Q1 201731640001564590-17-010026
10-K2017-03-01fiscal FY 2016401460001564590-17-003064
10-Q2016-11-04fiscal Q3 201631860001564590-16-027488
10-Q2016-08-04fiscal Q2 201631860001564590-16-022647
10-Q2016-05-04fiscal Q1 201635720001564590-16-017661
10-K2016-02-29fiscal FY 2015391450001564590-16-013759
10-Q2015-11-06fiscal Q3 2015351020001193125-15-368796
10-Q2015-08-06fiscal Q2 201533910001193125-15-279400
10-Q2015-05-01fiscal Q1 201538770001193125-15-163717
10-K2015-02-26fiscal FY 2014401470001193125-15-063338
10-Q2014-11-07fiscal Q3 2014351000001193125-14-402021
10-Q2014-08-01fiscal Q2 201432860001193125-14-290292
10-Q2014-05-08fiscal Q1 201432660001193125-14-188058
10-K2014-02-27fiscal FY 2013411380001193125-14-073093
10-Q2013-11-07fiscal Q3 201335940001193125-13-433110
10-Q2013-08-09fiscal Q2 201335920001193125-13-329063
10-Q2013-05-09fiscal Q1 201335720001193125-13-211264
10-K2013-03-01fiscal FY 2012411380001193125-13-085500
10-Q2012-11-09fiscal Q3 201236940001193125-12-463220
10-Q2012-08-09fiscal Q2 201236940001193125-12-347658
10-Q2012-05-04fiscal Q1 201236740001193125-12-209441
10-K2012-02-29fiscal FY 2011421640001193125-12-089389
10-Q2011-11-04fiscal Q3 201135900001193125-11-295663
10-Q2011-08-05fiscal Q2 201135900000950123-11-073714
10-Q2011-04-29fiscal Q1 201136740000950123-11-042000

Inspect the source

Entity
Nektar Therapeutics / CIK 0000906709
Captured
2026-09-20T05:05:37.584Z
SEC response SHA-256
e2600c46c7f668543c6f872627f345bdb6f22832099c13decf2fa4b7a0e4aabe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000906709.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))